The hazard ratio of the low-SOX4 is 1.65, and the hazard ratio of the median-SOX4 group is 1.46, which are both significantly greater compared with the hazard ration of 1 in the high-SOX4 group (P values of 0.006 and 0.0073 respectively (Figure 1), indicating that high SOX4 expression is strongly associated with the good prognosis of GBM patients. The gene discussed is SOX4; the disease is glioblastoma.